Tag: Aclaris Therapeutics
Braden Michael Leonard Acquires 150,000 Aclaris Therapeutics Shares
Braden Michael Leonard, a major shareholder in Aclaris Therapeutics, Inc. (NASDAQ:ACRS), recently acquired 150,000 shares of the company's stock in a transaction that took...